Your browser doesn't support javascript.
loading
Interferon-alpha plus low-dose cytosine arabinoside in advanced phase chronic myelogenous leukaemia patients.
Ferrajoli, A; Liberati, A M; Caricchi, P; Donti, E; Morra, E; Lazzarino, M; Betti, A R; Bernasconi, P; Saglio, G.
Affiliation
  • Ferrajoli A; Department of Internal Medicine and Oncological Sciences, University of Perugia, Italy.
Eur J Haematol ; 55(3): 184-8, 1995 Sep.
Article in En | MEDLINE | ID: mdl-7672091
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Interferon Type I / Cytarabine Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Haematol Journal subject: HEMATOLOGIA Year: 1995 Document type: Article Affiliation country: Italia Country of publication: Reino Unido
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Interferon Type I / Cytarabine Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Haematol Journal subject: HEMATOLOGIA Year: 1995 Document type: Article Affiliation country: Italia Country of publication: Reino Unido